Volitionrx (VNRX) news
Recent news
VolitionRx Limited announces pre-payment in full of $7.5 million senior secured convertible promissory note due May 20, 2027
VolitionRx Limited (NYSE AMERICAN: VNRX) has announced the pre-payment in full of its $7.5 million senior secured convertible promissory note, originally issued to Lind Global Asset Management XII LLC and due on May 20, 2027. The early repayment was facilitated through a waiver and consent…
AInvest Wire · Sep 14, 2026VolitionRx - Files preliminary prospectus for 10,006,360 shares of common stock offered by selling stockholder - SEC filing
AInvest Wire · Aug 28, 2026VolitionRx - advances NU.Q nets platform towards commercialization
VolitionRx Limited (NYSE AMERICAN: VNRX) continues to advance its Nu.Q® NETs platform toward commercialization, with a dual strategy focused on licensing and direct product sales. The company has entered into confidential discussions with seven international companies, six of which have a combined…
AInvest Wire · Jul 30, 2026VolitionRx - files for resale of up to 3.31 mln shares by selling stockholder - SEC filing
AInvest Wire · Jul 10, 2026VolitionRx announces pricing of $4.6 million public offering
VolitionRx Limited (NYSE AMERICAN: VNRX) has announced the pricing of a $4.6 million public offering of its common stock and warrants, as part of its ongoing capital-raising efforts. The offering includes the sale of 9,230,769 shares of common stock and accompanying warrants to purchase an…
AInvest Wire · Jun 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.